Cargando…
Pharmacokinetics of the SABRE agent 4,6-d(2)-nicotinamide and also nicotinamide in rats following oral and intravenous administration
To prepare the way for using the isotopically labelled SABRE hyperpolarized 4,6-d(2)-nicotinamide as an MRI agent in humans we have performed an in-vivo study to measure its pharmacokinetics in the plasma of healthy rats after intravenous and oral administration. Male Han Wistar rats were dosed with...
Autores principales: | Linnik, Inna V., Rayner, Peter J., Stow, Ruth A., Duckett, Simon B., Cheetham, Graham M.T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science B.V
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556870/ https://www.ncbi.nlm.nih.gov/pubmed/31077749 http://dx.doi.org/10.1016/j.ejps.2019.05.004 |
Ejemplares similares
-
Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.
por: Rojas, A., et al.
Publicado: (1993) -
Oral Administration of Nicotinamide Mononucleotide Increases Nicotinamide Adenine Dinucleotide Level in an Animal Brain
por: Ramanathan, Chidambaram, et al.
Publicado: (2022) -
SABRE hyperpolarized anticancer agents for use in (1)H MRI
por: Fear, Elizabeth J., et al.
Publicado: (2022) -
Nicotinamide Administration Improves Remyelination after Stroke
por: Wang, Congxiao, et al.
Publicado: (2017) -
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
por: Okabe, Keisuke, et al.
Publicado: (2022)